SCHEMBL3352453

SCHEMBL3352453

C[CH]OCc1ccc(Cl)cc1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 3/20 0.52
AGXT P21549 2/20 0.52
MAOB P27338 5/20 0.42
APP P05067 1/20 0.42
MAOA P21397 1/20 0.41
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
KMT2A Q03164 1/20 0.39
SLC6A2 P23975 2/20 0.39
SLC6A3 Q01959 2/20 0.39
TAAR1 Q96RJ0 2/20 0.39
HTR2A P28223 1/20 0.39
SLC6A4 P31645 1/20 0.39
HRH1 P35367 1/20 0.39
HTR2B P41595 1/20 0.39
CHRNA4 P43681 1/20 0.39
CCR5 P51681 1/20 0.38
TACR2 P21452 1/20 0.38
NR4A2 P43354 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6232832 0.78 IDO1 (0.48) IDO1AGXTMAOBAPPMAOA
SCHEMBL8743208 0.77 IDO1 (0.52) IDO1MAOBAPPMAOAKMT2A
SCHEMBL8817 0.77 IDO1 (0.52) IDO1AGXTMAOBAPPMAOA
SCHEMBL353572 0.77 IDO1 (0.52) IDO1AGXTMAOBAPPMAOA
SCHEMBL58206 0.76 TSHR (0.52) IDO1AGXTMAOBSLC6A2SLC6A3
SCHEMBL7189732 0.76 IDO1 (0.57) IDO1AGXTMAOBAPPNPC1
SCHEMBL10887507 0.75 IDO1 (0.45) IDO1AGXTMAOBAPPMAOA
SCHEMBL10724826 0.74 APP (0.49) APPNPC1RAB9AKMT2ANR4A2
SCHEMBL31273 0.73 IDO1 (0.58) IDO1AGXTMAOBAPPMAOA
SCHEMBL444754 0.73 LOXL2 (0.41) HRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118215477-A Mitochondrial pyruvate carrier inhibitors [1,2,4] triazolo [4,3-a ] pyrimidin-7 (8H) -one for the treatment of cancer MPC治疗中心 2024-06-18 CN disclosed
WO-2010067102-A1 DIAZASPIRO [5.5] UNDECANE DERIVATIVES AND RELATED COMPOUNDS AS MUSCARINIC-RECEPTOR ANTAGONISTS AND BETA-ADRENORECEPTOR AGONISTS FOR THE TREATMENT OF PULMONARY DISORDERS ASTRAZENECA AB (SE) 2010-06-17 WO disclosed